Patents by Inventor Sandra McLachlan

Sandra McLachlan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inverse agonist monoclonal antibody that suppresses thyrotropin receptor constitutive activity
    Patent number: 8350012
    Abstract: This invention describes monoclonal antibodies that suppress thyrotropin receptor constitutive activity and methods of using the antibodies to treat thyroid related diseases; particularly hyperthyroidism and thyroid cancer.
    Type: Grant
    Filed: January 24, 2008
    Date of Patent: January 8, 2013
    Assignee: Cedars-Sinai Medical Center
    Inventors: Basil Rapoport, Sandra McLachlan, Chun-Rong Chen
  • MONOCLONAL ANTIBODY THAT SUPPRESSES THYROTROPIN RECEPTOR CONSTITUTIVE ACTIVITY
    Publication number: 20110014200
    Abstract: This invention describes monoclonal antibodies that suppress thyrotropin receptor constitutive activity and methods of using the antibodies to treat thyroid related diseases; particularly hyperthyroidism and thyroid cancer
    Type: Application
    Filed: January 24, 2008
    Publication date: January 20, 2011
    Applicant: CEDARS-SINAI MEDICAL CENTER
    Inventors: Basil Rapoport, Sandra McLachlan, Chun-Rong Chen
  • Nucleic acid encoding human thyrotropin receptor
    Patent number: 6747139
    Abstract: Nucleic acids encoding human thyrotropin receptor and related methods are disclosed. The nucleic acids may have nucleotides deleted and/or replaced to modify the amino acid sequence of human thyrotropin receptor.
    Type: Grant
    Filed: November 5, 1998
    Date of Patent: June 8, 2004
    Assignee: Quest Diagnostics Investments, Inc.
    Inventors: Basil Rapoport, Sandra McLachlan